Recently, degradation of imipramine,1 ) digoxin,2,3) and nitroglycerin4) by the intestinal microflora has been investigated in order to explain their low extents of bioavailability after oral administration to man. In the case of sulfinpyrazone,5) the distal gut with its microflora is the principal and possibly the only site of reduction of sulfinpyrazone to its active form in humans, and metabolism of the drug by the gut flora is essential to its pharmacological response. Bromazepam, one of the 1,4-benzodiazepine antianxiety agents, has also been reported to exhibit low bioavailability after oral administration. Kasama et al.6) reported that the area under the plasma concentration-time curve (A UC) value after rectal administration of 3 mg of bromazepam was equivalent to that after oral administration of 5 mg of bromazepam. The present study was undertaken to investigate the possible degradation of bromazepam in fresh human feces. centrifuged at 3000 rpm for 20 min and the organic phase was then evaporated in vacuo at 60 °C. The residue was dissolved in 50 pl of methanol and a 10-pl aliquot of the resultant solution was injected into the high performance liquid chromatography (HPLC) system (LC-4A, Shimadzu Manufacturing Co., Kyoto) equipped with a ultraviolet (UV) detector set at 233 nm. A 150 mm column of Shim-pack CLC-ODS (particle size 5 pm, Shimadzu Manufacturing Co.) was employed with a mobile phase of methanol : water : ammonium hydroxide = 270 : 230 : 3 at the flow rate of 1.0 ml/min at a column temperature of 50 °C. Decrease in bromazepam concentration with time was expressed as the ratio of peak area of bromazepam/peak area of the internal standard at the sampling time divided by that at time zero.
Identification of the Degradation Product An extract from fecal culture medium after incubation was spotted on a silica gel plate (Kieselgel 60 F2 Kanto Chemical Co., Tokyo), developed in acetone : chloroform = 10 : 90 and visualized under UV light. The extract was also examined by gas chromatography-mass spectrum (GC-MS) analysis (QP-1000 GC-MS .system, Shimadzu Manufacturing Co.). The GC part of the GC-MS system was equipped with a 1-m glass column packed with 3% OV-17 on Chromosorb Q. The flow rate of helium was 50 ml/min. The temperatures of the injection port, column, transfer line to the MS system, and ion source of the MS system were 275, 250, 280, and 280 °C, resPectively. MS were obtained in an electron impact (EI) mode at an electron energy of 70 eV.
Metabolism in Homogenates of Liver and Intestinal Epithelial Cells in Rats An 8-ml portion of 0.1 rvi Tris HC1 buffer solution, pH 7.4 was added to 2 g each of the excised liver mass and intestinal epithelial cells of rat. Saline was introduced into the artery of the excised liver of a rat to remove blood, and the tissue was homogenized (Physcotron, Nichi-on Co., Chiba). Everted rat intestine was scraped with a slide glass to collect epithelial cells. Both mixtures were homogenized and centrifuged at 3000 rpm for 10 min. A 50-pl portion of bromazepam solution (2 mg/ml) in ethanol was added to 0.95 ml of the supernatant, and then the mixture was incubated at 37 °C. A 50-pl aliquot was collected after incubation for 0, 1, 2, 3, 4, and 5 h, and )nu v| of acetonitrile containing clonazepam as an internal standard (50 pg/ml) was immediately added to deproteinize the sample. Each mixture was centrifuged at 7000 rpm for 2 min. A 2-pl portion of each supernatant was injected into the HPLC system.
The HPLC conditions were identical to those given earlier in the section on determination of undegraded drugs. Total amounts of protein in the supernatant of homogenates of the rat liver and intestinal epithelial cells in this study were determined by the Lowry method.
Results and Discussion Figure 1 shows the degradation profiles of four benzodiazepines in the broth containing 8% human feces. Bromazepam was rapidly degraded in the broth at 37 °C, while the other three benzodiazepines were not degraded up to 5 h. About 80% of bromazepam was degraded within 5 h under both anaerobic and aerobic conditions, while it was not degraded in the sterilized fecal culture, indicating that degradation of bromazepam was not caused by the fecal contents themselves but by the gut microflora. The degradability of bromazepam may be related to the fact that this compound is the only one containing a pyridine ring, among those tested. Disappearance profiles of bromazepam in homogenates of the liver, intestinal epithelial cells, and the fecal flora of rats are shown in Fig. 2 . Total amounts of protein in the supernatant of homogenates of the liver and intestinal epithelial cells of rats were 29.4 and 22.5 mg/ml, respectively. Percentages of degradation of bromazepam by the liver and intestinal epithelial cells in rats were about 10% each, while that by rat feces was about 30% in 5 h. Degradation of bromazepam in homogenates of fecal cultures in rats was observed from 3 h after the initiation of incubation, presumably reflecting the time required for the growth of bacteria in a rat microfloral culture.
Kasama et al.') observed lower bioavailability of bromazepam after oral administration than after rectal administration. Fukushima et al.') reported that the plasma concentrations of bromazepam after rectal administration were higher than those after oral administration to 12 healthy volunteers. The A UC after rectal administration of bromazepam was about twice that after oral administration. Kasama et al.') also reported on the pharmacokinetics after oral administration of 5 mg of bromazepam and rectal administration of 3 mg of bromazepam to 7 healthy volunteers. The AUC0_ co values after rectal administration of 3 mg were equivalent to those after oral administration of 5 mg, suggesting 60% relative bioavailability of bromazepam after oral administration of bromazepam with respect to bioavailability after rectal administration. Thus, one of the major reasons why low bioavailability was observed after oral administration of bromazepam is considered to be degradation of the drug by the intestinal microflora.
On a thin layer chromatogram, the Rf values for bromazepam and its degradation product were 0.04 and 0.64, respectively, and no other spot was detected by this method. A major metabolite of bromazepam separated by TLC was identical with authentic 2-(2-amino-5-bromobenzoyl) pyridine on GC-MS analysis, as shown in Fig. 3 . Thus, the degradation of bromazepam in intestinal microflora may be represented by the scheme shown in Chart 2.
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